pancreatitis with glp 1 GLP-1 Drugs for Diabetes and Obesity: May Reduce Risk of Acute glp 1 pancreatitis symptoms GLP-1

Biochem Biophys Res Commun 405 , 173179, doi: 10.1016/j.bbrc.2011.01.002 (2011)

Mechanism of Action: How Ipamorelin Releases GH Ipamorelin binds to the GHS-R1a receptor on anterior pituitary somatotroph cells

10.3322/caac.21660 42 TakahashiN.SaitoD.HasegawaS.YamasakiM.ImaiM

Mochi Health is a newer, weight-focused platform

The researchers said they don't know whether the effects will persist when people have been taking the drugs for many years, or whether the brain will adapt and the GLP-1 effects will weaken

Clinical trials have shown that after stopping the weight loss medication, patients tend to regain two-thirds of their weight back in one year